These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 31071370)
1. Cationic block amphiphiles show anti-mitochondrial activity in multi-drug resistant breast cancer cells. Czupiel PP; Delplace V; Shoichet MS J Control Release; 2019 Jul; 305():210-219. PubMed ID: 31071370 [TBL] [Abstract][Full Text] [Related]
2. Nanoparticle delivery of a pH-sensitive prodrug of doxorubicin and a mitochondrial targeting VES-H Czupiel P; Delplace V; Shoichet M Sci Rep; 2020 May; 10(1):8726. PubMed ID: 32457422 [TBL] [Abstract][Full Text] [Related]
3. Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat. Tripathi AK; Kumari T; Tandon A; Sayeed M; Afshan T; Kathuria M; Shukla PK; Mitra K; Ghosh JK Acta Biomater; 2017 Jul; 57():170-186. PubMed ID: 28483698 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel aliphatic acid-conjugated antimicrobial peptides as potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability. Zhang B; Gu H; Shi W; Li H; Ma G; Chen X; Qian H; Lin H; Huang W; Ge L Amino Acids; 2017 Nov; 49(11):1831-1841. PubMed ID: 28831625 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway. Yang L; Cui Y; Shen J; Lin F; Wang X; Long M; Wei J; Zhang H Drug Des Devel Ther; 2015; 9():1319-30. PubMed ID: 25767377 [TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537 [TBL] [Abstract][Full Text] [Related]
7. New derivatives of lupane triterpenoids disturb breast cancer mitochondria and induce cell death. Serafim TL; Carvalho FS; Bernardo TC; Pereira GC; Perkins E; Holy J; Krasutsky DA; Kolomitsyna ON; Krasutsky PA; Oliveira PJ Bioorg Med Chem; 2014 Nov; 22(21):6270-87. PubMed ID: 25245673 [TBL] [Abstract][Full Text] [Related]
8. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability. Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942 [TBL] [Abstract][Full Text] [Related]
9. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597 [TBL] [Abstract][Full Text] [Related]
10. α-Tocopherol-ascorbic acid hybrid antioxidant based cationic amphiphile for gene delivery: Design, synthesis and transfection. Muripiti V; Brijesh L; Rachamalla HK; Marepally SK; Banerjee R; Patri SV Bioorg Chem; 2019 Feb; 82():178-191. PubMed ID: 30326400 [TBL] [Abstract][Full Text] [Related]
11. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction. Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of Apoptotic New Quinazolinone-Based Compound and Identification of its Underlying Mitochondrial Signalling Pathway in Breast Cancer Cells. Zahedifard M; Faraj FL; Paydar M; Looi CY; Hasandarvish P; Hajrezaie M; Kamalidehghan B; Majid NA; Khalifa SA; Ali HM; Abdulla MA; El-Seedi HR Curr Pharm Des; 2015; 21(23):3417-26. PubMed ID: 25808938 [TBL] [Abstract][Full Text] [Related]
13. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts. Hilchie AL; Doucette CD; Pinto DM; Patrzykat A; Douglas S; Hoskin DW Breast Cancer Res; 2011 Oct; 13(5):R102. PubMed ID: 22023734 [TBL] [Abstract][Full Text] [Related]
14. Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity. Chu DS; Bocek MJ; Shi J; Ta A; Ngambenjawong C; Rostomily RC; Pun SH J Control Release; 2015 May; 205():155-61. PubMed ID: 25596326 [TBL] [Abstract][Full Text] [Related]
15. Engineered apoptosis-inducing peptides with enhanced mitochondrial localization and potency. Horton KL; Kelley SO J Med Chem; 2009 May; 52(10):3293-9. PubMed ID: 19397319 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities. Zhang B; Shi W; Li J; Liao C; Yang L; Huang W; Qian H Chem Biol Drug Des; 2017 Nov; 90(5):972-980. PubMed ID: 28524273 [TBL] [Abstract][Full Text] [Related]
17. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism. Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928 [TBL] [Abstract][Full Text] [Related]
18. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate. Singh Y; Viswanadham KKDR; Pawar VK; Meher J; Jajoriya AK; Omer A; Jaiswal S; Dewangan J; Bora HK; Singh P; Rath SK; Lal J; Mishra DP; Chourasia MK Mol Pharm; 2019 Sep; 16(9):3744-3759. PubMed ID: 31441308 [TBL] [Abstract][Full Text] [Related]
19. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419 [TBL] [Abstract][Full Text] [Related]
20. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer. Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]